Since crosstalk exists between metastasis and drug resistance 5-9, we further detected the expression of miR-302a, NFIB and CD44 in a metastatic tissue microarray (TMA 2), which contained paired normal colon tissue, primary CRC tissue and distant metastatic tissue samples from 14 cases. This evidence concerns the gene NFIB and colorectal carcinoma.